EverydayHealthLogo
Dr. Mark K Buyyounouski, MD
TOP DOCTOR

Dr. Mark K Buyyounouski, MD

Radiologist

17 Years of Experience

Accepting patients

    Overview

    Dr. Mark Buyyounouski, MD is a Radiologist, who primarily practices in Philadelphia, PA. He has been practicing for over 17 years and is board certified by the American Board of Radiology. Dr. Buyyounouski graduated from UMDNJ - NJMS and completed his residency at Fox Chase Cancer Ctr, Radiation Oncology; St Barnabas Med Ctr, Internal Medicine. Dr. Buyyounouski is fluent in English and is currently seeing new patients. Dr. Buyyounouski’s practice accepts Medicare, Humana Health, Aetna, Cigna, UnitedHealthcare, Medicaid, Blue Cross Blue Shield (BCBS) and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Buyyounouski’s office at (215) 728-6900.
    CastleConnolyTopDoctors

    Castle Connolly Top Doctor

    Castle Connolly Top Doctors are doctor-nominated and selected by a physician-led research team.

    Medical Specialties and Areas of Expertise

    Radiologist

    Education & Training

    Fox Chase Cancer Ctr, Radiation Oncology; St Barnabas Med Ctr, Internal Medicine (Residency)

    Fox Chase Cancer Center (Residency)

    St Barnabas Medical Center (Internship)

    Other Degree - Umdnj-New Jersey Med Sch- Newark Nj

    Medical Degree - UMDNJ - NJMS

    Board Certifications

    American Board of Radiology since 2006

    Medical Procedures Performed

    procedures performed by a Radiologist, like Dr. Mark Buyyounouski, may include:

    CT Scan - Lungs, CT Scan - Heart (Coronary CTA), CT Scan - Head, CT Scan - Teeth (Dental Scan), CT Scan - Virtual Colonoscopy, CT Scan - Whole Body Scan, CT Scan - Other, MRI - Brain, MRI - Breast, MRI - Back / Spine, MRI - Other, PET / CT Scan, X-ray, Mammography - No Breast Cancer History, Bone Density Measurement / DXA Scan, Sonography, Radiology Consultation, MRI - Brain, Mammography - With Breast Cancer History, SPECT Scan, PET Scan, Interventional Radiology Treatment, Angiography, Embolization, IVC Filter Insertion, MRI - Spinal Cord, CT Scan - Spinal Cord, MRI Angiography, CT Angiography, Mesenteric Angiography, Barium Swallow, Calcium CT Scan, Leg Venous Doppler, KG Arterial Doppler, Neurosonology Consultation, Myelogram, TIPS / Biliary Interventions, Ventilation / Perfusion Scan, CT Scan - Abdominal / Pelvic, CT Scan - Chest, Dialysis Catheter Placement, Drainage of Abscess, Feeding Tube Placement, Fluoroscopy, Line Insertion, MRI - Abdomen / Pelvis, MRI - Head, MRI - Knee, MRI - Shoulder, Bone Scan, Brain / Spinal Cord Biopsy, Pelvic Ultrasound, Radiofrequency Ablation, Radioimmunotherapy, Cryoablation, Interventional Radiology Consultation, Cone Beam CT, Arthrography, Sialography, Skeletal Imaging, Hybrid Imaging, Renal Function Imaging, Urinary Tract Imaging, Abdominal Imaging, Molecular Imaging, Chemoembolization, Digital Radiography, Radioembolization, Image-Guided Cancer Therapy, Thrombectomy, Nuclear Medicine Imaging, Diagnostic Radiology, EOS Imaging, Drug-Eluting Bead Therapy, Abdominal Radiology Consultation, Intravascular Ultrasound, Interventional Radiology Follow Up, Needle Biopsy, Lung Biopsy, Bone Biopsy, Abdominal Aortic Aneurysm (AAA) Screening, Fistulagram and Uterine Fibroid Embolization (UFE)

    For detailed information, please contact Dr. Buyyounouski's office.

    Insurances

    Top Insurances

    • Aetna

    • Blue Cross Blue Shield (BCBS)

    • Cigna

    • Humana Health

    • Medicaid

    • Medicare

    • UnitedHealthcare

    View All Insurances

    Locations

    Practice At 333 Cottman Ave Fox Chase Cancer Center

    333 Cottman Ave

    Fox Chase Cancer Center

    Philadelphia, PA 19111

    (215) 728-6900

    Get Directions | View Website

    Recognitions

    Publications

    Potential Treatment Margin Reduction for Prostate Treatment with RapidArc and VMAT

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    Five Year Results of a R

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    Genetic Polymorphisms of D Repair

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    Prostate Bed Motion during Intensity Modulated Radiotherapy Treatment

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    Treatment-related Side Effects And Quality Of Life Among Prostate Cancer Patients Treated With

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    Implantation of electromagnetic transponders following radical prostatectomy for delivery of IMRT

    CADIAN JOURL OF UROLOGY, 2010

    STEREOTACTIC BODY RADIOTHERAPY FOR EARLY-STAGE NON-SMALL-CELL LUNG CANCER

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    RADIOTHERAPY PSA dir predicts long-term mortality

    TURE REVIEWS CLINICAL ONCOLOGY, 2010

    STEREOTACTIC BODY RADIOTHERAPY FOR PRIMARY MAGEMENT OF EARLY-STAGE

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    Evaluation of the Prostate Cancer Prevention Trial Risk calculator in a high

    BJU INTERTIOL, 2010

    Young Age under 60 is not a Contraindication to Treatment with Definitive High Dose Exterl Beam

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    Intermediate-risk Prostate Cancer Treated with High Dose Radiotherapy Alone or in Combition with

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    Low Pretreatment PET SUV Predicts for Incre

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    The Stamp Test Delivers the Message on Erectile Dysfunction following High Dose IMRT

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    Prelimiry Results of RTOG 0233

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    A Practical Strategy to Correct Prostate Rotation Reported by a 4D Localization System

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    Interval to Biochemical Failure is Highly Prognostic for Distant Metastases

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    Conventiol versus Hypofractioted IMRT

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    The Role of Adjuvant and Salvage Post-Prostatectomy IMRT or 3DCRT: The Fox Chase Experience

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    GAINS FROM REAL-TIME TRACKING OF PROSTATE MOTION DURING EXTERL BEAM RADIATION THERAPY

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009

    Androgen Deprivation Therapy and Prostate Cancer Duration

    JOURL OF CLINICAL ONCOLOGY, 2009

    Optimal PET response following stereotactic body radiotherapy

    JOURL OF THORACIC ONCOLOGY, 2009

    Fil report of a phase I Dose Escalation Trial of Stereotactic Body Radiotherapy

    JOURL OF THORACIC ONCOLOGY, 2009

    RTOG GU RADIATION ONCOLOGY SPECIALISTS REACH CONSENSUS ON PELVIC LYMPH NODE VOLUMES FOR HIGH

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009

    Correlation of hypoxic prostate/muscle p(O2) (P/M P-O2) ratio

    JOURL OF CLINICAL ONCOLOGY, 2009

    Residual Prostate Cancer After Radiotherapy

    JOURL OF UROLOGY, 2009

    Initial PSA (iPSA) and Radiation Dose Predict for an Undetectable PSA following 3DCRT or IMRT for

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009

    Defining Biochemical Failure following Salvage Radiotherapy

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009

    A Potential Outcomes Framework to Determine Whether Age

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009

    Is MRI-based Week Three Post-implant Dosimetry Necessary following LDR Prostate Brachytherapy?

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009

    Validating the Interval to Biochemical Failure

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009

    Undetectable Post-treatment PSA following 3DCRT or IMRT Alone for Patients with Low or Intermediate

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009

    Hypofractiotion for Prostate Cancer: Interim Results of a Randomized Trial

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009

    DOES TREATMENT DURATION AFFECT OUTCOME AFTER RADIOTHERAPY FOR PROSTATE CANCER?

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Comment on dose escalation and biochemical failure in prostate cancer

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    A comparison of acute

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Influence of local tumor control on distant metastases and cancer related mortality after exterl

    JOURL OF UROLOGY, 2008

    How can men destined for biochemical failure after androgen deprivation and radiotherapy be

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Percentage of biopsy cores positive for maligncy

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Commentary on dose escalation and biochemical failure in prostate cancer

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Predicting local persistence of intermediate

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Interval to biochemical failure highly prognostic for distant metastasis

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Low morbidity and excellent local control using image guided stereotactic body radiotherapy

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Gains from real-time prostate motion monitoring during exterl beam radiation therapy

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    The optimum duration of combition androgen deprivation therapy

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Androgen deprivation therapy plus hypofractioted prostate radiotherapy

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Radiation therapy for high risk prostate cancer

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Estimating gains in biochemical outcome from various durations of

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    PSA doubling time predicts for the development of distant metastases

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Prostate cancer risk assessment program: A 10-year update of cancer detection

    JOURL OF UROLOGY, 2007

    What dose of exterl-beam radiation is high enough for prostate cancer?

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007

    Identification of a Single Nucleotide Polymorphism Related to Late Toxicity in a R

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    Randomized trial of hypofractioted exterl-beam radiotherapy for prostate cancer.

    Jourl of clinical oncology, 2013

    Gleason Scoring at a Comprehensive Cancer Center: What's The Difference?

    JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK, 2013

    Validating the Interval to Biochemical Failure

    JOURL OF CLINICAL ONCOLOGY, 2012

    RADIOTHERAPY DOSES OF 80 GY AND HIGHER ARE ASSOCIATED WITH LOWER MORTALITY IN MEN WITH GLEASON

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    DEVELOPMENT OF RTOG CONSENSUS GUIDELINES FOR THE DEFINITION OF THE CLINICAL TARGET VOLUME FOR

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    Inflammatory Bowel Disease Is Not an Absolute Contraindication to Definitive Radiation Therapy

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013

    CT-MRI Fusion Uncertainty in Prostate Treatment Planning for Different Image Guidance Techniques

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013

    Toxicity and Biochemical Failure Following Image

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013

    Improved Outcomes in Men Treated With Adjuvant

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013

    Stratifying intermediate-risk patients for radiotherapy

    TURE REVIEWS UROLOGY, 2013

    Reduction of prostate intrafractiol motion from shortening the treatment time

    PHYSICS IN MEDICINE AND BIOLOGY, 2013

    A Novel Method for Predicting Late Genitouriry Toxicity After Prostate Radiation Therapy

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013

    Untitled Reply

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013

    In reply to Cheung.

    Intertiol jourl of radiation oncology, biology, physics, 2013

    Prospective Validation of Diagnostic Tumor Tissue Ki

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    Primary Prostate Radiation Therapy: Where Are We Failing?

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    Determints of Prostate Biopsy Positivity 2 Years After Radiation Therapy

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    Do Testosterone Kinetics After Radiation Therapy (RT) Predict Biochemical Failure (BCF) for Low-

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    Recursive Partitioning Alysis of Intermediate Risk Prostate Cancer Patients Identifies Subgroup

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    A Novel Methodology to Predict Late Uriry Toxicity Following Prostate Radiation Therapy

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    Aspirin and Statin Nonuse Associated With Early Biochemical Failure After Prostate Radiation

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    Prostate Bed Motion During Intensity-Modulated Radiotherapy Treatment

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    Radiotherapy Treatment Planning for Testicular Seminoma

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    Magnetic Resonce Spectroscopy of the Prostate: A Phantom Study of Metabolite Concentrations

    MEDICAL PHYSICS, 2012

    Effect of Gold Marker Seeds on Magnetic Resonce Spectroscopy of the Prostate

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    Testicular Cancer Clinical Practice Guidelines in Oncology

    JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK, 2012

    Hypoxic Prostate/Muscle PO2 Ratio Predicts for Outcome in Patients With Localized Prostate Cancer

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    Long-Term Survival After Radical Prostatectomy Versus Exterl

    CANCER, 2011

    INTENSITY-MODULATED RADIOTHERAPY REDUCES GASTROINTESTIL TOXICITY IN PATIENTS TREATED WITH ANDROGEN

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    PREDICTORS OF ANDROGEN DEPRIVATION THERAPY EFFICACY COMBINED WITH PROSTATIC IRRADIATION

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    The Impact of Gleason Scoring at a Comprehensive Cancer Center

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    A Nomogram Predicting 5

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    Aspirin Use Reduces the Risk of Biochemical Failure

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    A Family History of Prostate Cancer is not Associated with Poorer Outcomes following Radiotherapy

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    VMAT Reduces Moderate to High Integral Dose When Compared to Conventiol IMRT

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    Predicting local persistence of intermediate

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Interval to biochemical failure highly prognostic for distant metastasis

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Low morbidity and excellent local control using image guided stereotactic body radiotherapy

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Gains from real-time prostate motion monitoring during external beam radiation therapy

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    The optimum duration of combination androgen deprivation therapy

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    The phoenix definition of biochemical failure predicts for overall survival

    CANCER, 2008

    Androgen deprivation therapy plus hypofractionated prostate radiotherapy

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Radiation therapy for high risk prostate cancer

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Estimating gains in biochemical outcome from various durations of

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    PSA doubling time predicts for the development of distant metastases for patients who fail 3DCRT

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Prostate cancer risk assessment program: A 10-year update of cancer detection

    JOURNAL OF UROLOGY, 2007

    Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer.

    Journal of clinical oncology, 2013

    Transurethral surgery

    LANCET ONCOLOGY, 2013

    Gleason Scoring at a Comprehensive Cancer Center: What's The Difference?

    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013

    Assessment of the American Joint Committee on Cancer Staging

    CANCER, 2012

    Validating the Interval to Biochemical Failure

    JOURNAL OF CLINICAL ONCOLOGY, 2012

    Timing of biochemical failure and distant metastatic disease for low-, intermediate-

    CANCER, 2007

    What dose of external-beam radiation is high enough for prostate cancer?

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007

    Daily localization for prostate bed patients based on surgical clips

    MEDICAL PHYSICS, 2007

    Dosimetric comparison of 4D and 3 multi-phase CT imaging for stereotactic body radiation therapy

    MEDICAL PHYSICS, 2007

    Surface smoothing of a tubular structure using a non-shrinking algorithm

    MEDICAL PHYSICS, 2007

    Do stranded seeds improve the quality of permanent prostate seed

    RADIOTHERAPY DOSES OF 80 GY AND HIGHER ARE ASSOCIATED WITH LOWER MORTALITY IN MEN WITH GLEASON

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    DEVELOPMENT OF RTOG CONSENSUS GUIDELINES FOR THE DEFINITION OF THE CLINICAL TARGET VOLUME FOR

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    Inflammatory Bowel Disease Is Not an Absolute Contraindication to Definitive Radiation Therapy

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013

    CT-MRI Fusion Uncertainty in Prostate Treatment Planning for Different Image Guidance Techniques

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013

    Toxicity and Biochemical Failure Following Image

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013

    Improved Outcomes in Men Treated With Adjuvant or Early Salvage Postprostatectomy IMRT

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013

    Stratifying intermediate-risk patients for radiotherapy

    NATURE REVIEWS UROLOGY, 2013

    Reduction of prostate intrafractional motion from shortening the treatment time

    PHYSICS IN MEDICINE AND BIOLOGY, 2013

    A Novel Method for Predicting Late Genitourinary Toxicity After Prostate Radiation Therapy

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013

    Untitled Reply

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013

    In reply to Cheung.

    International journal of radiation oncology, biology, physics, 2013

    The impact of dose-escalated radiotherapy plus

    CANCER, 2013

    Prospective Validation of Diagnostic Tumor Tissue Ki

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    Primary Prostate Radiation Therapy: Where Are We Failing?

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    Determinants of Prostate Biopsy Positivity 2 Years After Radiation Therapy

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    Do Testosterone Kinetics After Radiation Therapy (RT) Predict Biochemical Failure (BCF) for Low-

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    Recursive Partitioning Analysis of Intermediate Risk Prostate Cancer Patients Identifies Subgroup

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    A Novel Methodology to Predict Late Urinary Toxicity Following Prostate Radiation Therapy

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    Aspirin and Statin Nonuse Associated With Early Biochemical Failure After Prostate Radiation

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    Prostate Bed Motion During Intensity-Modulated Radiotherapy Treatment

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    Stamp Test Delivers Message on Erectile Dysfunction After High-dose Intensity

    UROLOGY, 2012

    Radiotherapy Treatment Planning for Testicular Seminoma

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    A survey of current clinical practice in permanent and temporary prostate brachytherapy

    BRACHYTHERAPY, 2012

    Magnetic Resonance Spectroscopy of the Prostate: A Phantom Study of Metabolite Concentrations

    MEDICAL PHYSICS, 2012

    How Certain Can the Real-Time Plan Predict the Post Dosimetry for Prostate Seed Implant?

    MEDICAL PHYSICS, 2012

    Effect of Gold Marker Seeds on Magnetic Resonance Spectroscopy of the Prostate

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    Biochemical and clinical experience with real

    BRACHYTHERAPY, 2012

    Testicular Cancer Clinical Practice Guidelines in Oncology

    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012

    An evidence based review of proton beam therapy

    RADIOTHERAPY AND ONCOLOGY, 2012

    Hypoxic Prostate/Muscle PO2 Ratio Predicts for Outcome in Patients

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    Young age under 60 years is not a contraindication to treatment with definitive dose escalated

    RADIOTHERAPY AND ONCOLOGY, 2011

    Long-Term Survival After Radical Prostatectomy Versus External

    CANCER, 2011

    INTENSITY-MODULATED RADIOTHERAPY REDUCES GASTROINTESTINAL TOXICITY IN PATIENTS TREATED WITH

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    PREDICTORS OF ANDROGEN DEPRIVATION THERAPY EFFICACY COMBINED WITH PROSTATIC IRRADIATION

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    The Impact of Gleason Scoring at a Comprehensive Cancer Center on the Ability to Predict Recurrence

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    A Nomogram Predicting 5

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    Aspirin Use Reduces the Risk of Biochemical Failure

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    A Family History of Prostate Cancer is not Associated with Poorer Outcomes following Radiotherapy

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    VMAT Reduces Moderate to High Integral Dose When Compared to Conventional IMRT

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    Identification of a Single Nucleotide Polymorphism Related to Late Toxicity in a R

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    Potential Treatment Margin Reduction for Prostate Treatment with RapidArc and VMAT

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    Five Year Results of a R

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    Genetic Polymorphisms of DNA Repair

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    Prostate Bed Motion during Intensity Modulated Radiotherapy Treatment

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    Treatment-related Side Effects And Quality Of Life Among Prostate Cancer Patients Treated With

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

    Implantation of electromagnetic transponders following radical prostatectomy for delivery of IMRT

    CANADIAN JOURNAL OF UROLOGY, 2010

    STEREOTACTIC BODY RADIOTHERAPY FOR EARLY-STAGE NON-SMALL-CELL LUNG CANCER

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    Androgen Deprivation Therapy in High-Risk Prostate Cancer

    ONCOLOGY-NEW YORK, 2010

    RADIOTHERAPY PSA nadir predicts long-term mortality

    NATURE REVIEWS CLINICAL ONCOLOGY, 2010

    STEREOTACTIC BODY RADIOTHERAPY FOR PRIMARY MANAGEMENT OF EARLY-STAGE

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    An intraoperative real-time sleeved seed technique for permanent prostate brachytherapy

    BRACHYTHERAPY, 2010

    Evaluation of the Prostate Cancer Prevention Trial Risk calculator in a high

    BJU INTERNATIONAL, 2010

    Young Age under 60 is not a Contraindication to Treatment with Definitive High Dose External Beam

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    Intermediate-risk Prostate Cancer Treated with High Dose Radiotherapy Alone or in Combination with

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    Low Pretreatment PET SUV Predicts for Incre

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    The Stamp Test Delivers the Message on Erectile Dysfunction following High Dose IMRT

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    Preliminary Results of RTOG 0233

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    A Practical Strategy to Correct Prostate Rotation Reported by a 4D Localization System

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    Interval to Biochemical Failure is Highly Prognostic for Distant Metastases

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    Conventional versus Hypofractionated IMRT

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    The Role of Adjuvant and Salvage Post-Prostatectomy IMRT or 3DCRT: The Fox Chase Experience

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    GAINS FROM REAL-TIME TRACKING OF PROSTATE MOTION DURING EXTERNAL BEAM RADIATION THERAPY

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009

    Androgen Deprivation Therapy and Prostate Cancer Duration

    JOURNAL OF CLINICAL ONCOLOGY, 2009

    Optimal PET response following stereotactic body radiotherapy

    JOURNAL OF THORACIC ONCOLOGY, 2009

    Final report of a phase I Dose Escalation Trial of Stereotactic Body Radiotherapy

    JOURNAL OF THORACIC ONCOLOGY, 2009

    Surveillance for Stage I Seminoma

    ONCOLOGY-NEW YORK, 2009

    RTOG GU RADIATION ONCOLOGY SPECIALISTS REACH CONSENSUS ON PELVIC LYMPH NODE VOLUMES FOR HIGH

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009

    Dosimetric comparison of stereotactic body radiotherapy using 4D CT

    RADIOTHERAPY AND ONCOLOGY, 2009

    Correlation of hypoxic prostate/muscle p(O2) (P/M P-O2) ratio

    JOURNAL OF CLINICAL ONCOLOGY, 2009

    Residual Prostate Cancer After Radiotherapy

    JOURNAL OF UROLOGY, 2009

    Race, Genetic West African Ancestry

    CANCER PREVENTION RESEARCH, 2009

    Initial PSA (iPSA) and Radiation Dose Predict for an Undetectable PSA following 3DCRT or IMRT for

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009

    Defining Biochemical Failure following Salvage Radiotherapy

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009

    A Potential Outcomes Framework to Determine Whether Age

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009

    Is MRI-based Week Three Post-implant Dosimetry Necessary following LDR Prostate Brachytherapy?

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009

    Validating the Interval to Biochemical Failure

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009

    Undetectable Post-treatment PSA following 3DCRT or IMRT Alone for Patients with Low or Intermediate

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009

    Hypofractionation for Prostate Cancer: Interim Results of a Randomized Trial

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009

    DOES TREATMENT DURATION AFFECT OUTCOME AFTER RADIOTHERAPY FOR PROSTATE CANCER?

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Residual prostate cancer after radiotherapy: A study of radical cystoprostatectomy specimens

    UROLOGY, 2008

    Comment on dose escalation and biochemical failure in prostate cancer

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    A comparison of acute

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Does transurethral resection of prostate

    UROLOGY, 2008

    Influence of local tumor control on distant metastases and cancer related mortality after external

    JOURNAL OF UROLOGY, 2008

    How can men destined for biochemical failure after androgen deprivation and radiotherapy be

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Percentage of biopsy cores positive for malignancy

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Commentary on dose escalation and biochemical failure in prostate cancer

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Frequently Asked Questions

    Is Dr. Mark Buyyounouski accepting new patients?

    Yes, Dr. Mark Buyyounouski is accepting new patients at this time.

    Does Dr. Mark Buyyounouski offer online booking?

    Please contact Dr. Buyyounouski's office at (215) 728-6900 for information about online booking, telehealth, or to schedule an appointment.

    Does Dr. Mark Buyyounouski offer telehealth appointments?

    Please contact Dr. Buyyounouski's office at (215) 728-6900 for information telehealth appointment availability or for scheduling assistance.

    Which language(s) does Dr. Mark Buyyounouski speak?

    Dr. Mark Buyyounouski speaks English.

    Which board certifications does Dr. Mark Buyyounouski have?

    Dr. Mark Buyyounouski is certified by the American Board of Radiology.

    Other Radiologist Near Philadelphia, PA

    Dr. Kathryn A Evers, MD
    Radiologist
    LocationPin-icon
    333 Cottman Ave, Philadelphia, PA 19111
    acceptingPatients-iconAccepting patients
    Dr. Kristin W Edwards, MD
    Radiologist
    LocationPin-icon
    333 Cottman Ave, Philadelphia, PA 19111
    acceptingPatients-iconAccepting patients
    Dr. Tiffany Tam, MD
    Radiologist
    LocationPin-icon
    333 Cottman Avenue, Philadelphia, PA 19111
    acceptingPatients-iconAccepting patients
    See All Specialists

    Doctors by Category

    Specialists